» Fibrinogen Reagent Kit

HEMOSTASIS COAGULATION ROUTINE SCREENING TESTS PT APTT FIBRINOGEN TT

Fibrinogen Reagent Kit

Chronometric assay

Fibrinogen assay based on the (modified) Clauss method.

For this routine hemostasis test, the clotting time of the diluted citrated plasma is determined in the presence of excess thrombin (≈ 80 IU / mL) and a reaction accelerator.

Access on the manufacturer's website TECHNOCLONE

Reference	4-5138005
Presentation	Kit
Number of assays	45
Quote

Price list, safety data sheets and notices are accessible to our registered customers.

Reference	Presentation	Number of assays	Quote	Product sheet
4-5138005	Kit	45

Price list, safety data sheets and notices are accessible to our registered customers.

Fibrinogen (Factor I) is a plasma soluble glycoprotein that is synthesized by the liver at a size of 340 kDa and circulating at a concentration of 2.6 to 3 mg/mL.
Fibrinogen is a dimer bound by disulfide bridges composed of 3 pairs of polypeptide chains not identical. Under the action of thrombin, fibrinogen is converted into fibrin. In combination with FXIII, calcium ions, fibrin forms a stable network that ensures coagulation.

A linear relationship exists between the logarithm of the clotting time and the logarithm of the concentration of fibrinogen. The kit reference 4-5138005 is composed of 5 vials of 2 mL of reagent and a vial for calibration.

- Linearity from 0.6 to 7 g / L
- Stable 5 days in analyzers
- No interference for :

Heparin : UFH: ≤ 2 IU / mL -> CBrN
Fibrinogen fragment ≤ 500mg / dL
Bilirubin : ≤ 0.4 mg / dL

- 5 vials x 2 mL lyophilized reagent
- 1 vial x 1 mL of Coagulation Reference

Coagulation Control A
Coagulation Control N
Coagulation Reference
TECHNOCLOT® Control A
TECHNOCLOT® Control N

	These kits are manufactured in accordance with the 98/79 EC directive for in vitro diagnostic devices. Only CE marked products can be used for diagnostic applications in Europe.
	These kits are intended for in vitro diagnostic use.
	These kits are for research use only and are not intended to be used for diagnostic procedures.
	Federal Drug Administration, FDA validates diagnostic kits for in vitro diagnostic use in the United States.
	Biological risk products.
	Storage between 2 and 8 ° C.
	Reactive in liquid form.
	Reactive in lyophilized form.
	Reactive in frozen form.
	Stability after opening at 2-8 ° C.
	Products that can be refrozen.
	Stability 12 months after refreezing at -20 ° C.
	Manufacturer.
	Importer
	Distributor.

HEMOSTASIS COAGULATION ROUTINE SCREENING TESTS PT APTT FIBRINOGEN TT